A detailed transcript-level probe annotation reveals alternative splicing based microarray platform differences.
BACKGROUND
Microarrays are a popular tool used in experiments to measure gene expression levels. Improving the reproducibility of microarray results produced by different chips from various manufacturers is important to create comparable and combinable experimental results. Alternative splicing has been cited as a possible cause of differences in expression measurements across platforms, though no study to this point has been conducted to show its influence in cross-platform differences.


RESULTS
Using probe sequence data, a new microarray probe/transcript annotation was created based on the AceView Aug05 release that allowed for the categorization of genes based on their expression measurements' susceptibility to alternative splicing differences across microarray platforms. Examining gene expression data from multiple platforms in light of the new categorization, genes unsusceptible to alternative splicing differences showed higher signal agreement than those genes most susceptible to alternative splicing differences. The analysis gave rise to a different probe-level visualization method that can highlight probe differences according to transcript specificity.


CONCLUSIONS
The results highlight the need for detailed probe annotation at the transcriptome level. The presence of alternative splicing within a given sample can affect gene expression measurements and is a contributing factor to overall technical differences across platforms.
Lee
Joseph C
JC
Genomics Core Laboratory, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. jclee8@gmail.com
Stiles
David
D
Lu
Jun
J
Cam
Margaret C
MC
D017398:Alternative Splicing; D016000:Cluster Analysis; D015342:DNA Probes / Q000032:analysis*; D030541:Databases, Genetic; D020869:Gene Expression Profiling; D005796:Genes; D006801:Humans; D046228:Microarray Analysis; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014407:Tumor Cells, Cultured
D015342:DNA Probes
BMC Genomics. 2005;6:63
15876355
BMC Bioinformatics. 2005;6:107
15850491
BMC Genomics. 2006;7:153
16776839
Genome Biol. 2006;7 Suppl 1:S12.1-14
16925834
Nat Biotechnol. 2006 Sep;24(9):1151-61
16964229
Mol Syst Biol. 2006;2:63
17102808
BMC Bioinformatics. 2007;8:108
17394657
Genome Res. 1999 Dec;9(12):1288-93
10613851
Nucleic Acids Res. 2001 Jul 1;29(13):2850-9
11433032
Science. 2002 May 3;296(5569):916-9
11988577
Nucleic Acids Res. 2003 Feb 15;31(4):e15
12582260
Nucleic Acids Res. 2003 Oct 1;31(19):5676-84
14500831
Nucleic Acids Res. 2004;32(9):e74
15161944
BMC Bioinformatics. 2004 Aug 14;5:111
15310390
BMC Genomics. 2004 Sep 2;5:61
15345031
Genome Biol. 2004;5(10):R73
15461792
Genome Biol. 2004;5(10):R74
15461793
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D501-4
15608248
J Comput Biol. 2004;11(5):945-70
15700411
Lancet. 2005 Feb 5-11;365(9458):454-5
15705441
Nat Methods. 2005 May;2(5):337-44
15846360
Nat Methods. 2005 May;2(5):345-50
15846361
Genomics. 2005 Jun;85(6):657-65
15885493
Trends Genet. 2006 Feb;22(2):101-9
16380191